CNUK has raised more than £350,000 for ClearSky Medical Diagnostics through its network of Angel investors to help develop its products to market-ready stage.

ClearSky Medical Diagnostics specialises in medical devices for the diagnosis and monitoring of Parkinson’s, Alzheimer’s and a range of other neurodegenerative conditions.

The company is a spinout company from the University of York’s Department of Electronics, established by co-founder and director Dr Stephen Smith and academics over the past ten years.

CNUK Medtech Solutions has helped ClearSky Medical Diagnostics in facilitating large scale clinical trials with major hospitals in Beijing and Shanghai and the development of its first two products.

LID-Monitor offers a safe, simple and unobtrusive way of monitoring dyskinesia. PD-Monitor assists specialists by measuring symptoms of Parkinson’s while patients undertake routine clinical tasks.